Autism Prevalence Rates in U.S. and Northern Ireland Continue to Rise
At the height of the fear and confusion associated with the declaration of a coronavirus pandemic public health emergency and strict social distancing regulations in the spring of 2020, U.S. health officials published a report that, in 2016, autism spectrum disorder (ASD) was estimated to affect one in 54 eight-year old children in the U.S., […]
Mandating a Novel Vaccine is a Novel Legal Issue
The emergency use authorization (EUA) granted to vaccine manufacturers by the U.S. Food and Drug Administration (FDA) to allow experimental COVID-19 vaccines to be distributed to the U.S. population states that the product is “an investigational vaccine not licensed for any indication” and requires that all “promotional material relating to the COVID-19 Vaccine clearly and […]
NIH Begins Testing Mixed COVID-19 Vaccine Schedules
The U.S. National Institutes of Health (NIH) has announced that it has begun an early stage Phase 1/2 clinical trial to examining what happens when an adult who is fully vaccinated with one type of COVID-19 vaccine, is given a different booster vaccine from another manufacturer three to four months later.1 Currently, there are three […]
Probable Link Found Between Pfizer’s COVID Shot and Heart Inflammation
On June 2, 2021, the Israeli Ministry of Health announced that it believes there is a “probable link” between Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19 and dozens of cases of myocarditis (inflammation of the heart) in Israel—mostly in males between 16-30 years of age. According to an epidemiological study undertaken by a […]
CDC Investigating Cases of Heart Inflammation After COVID-19 Vaccination
The U.S. Centers for Disease Control and Prevention (CDC) has begun an investigation into reports of myocarditis (heart inflammation) in people between 16 and 45 years of age after receiving either the genetically engineered experimental messenger ribonucleic acid (mRNA) BNT162b2 and mRNA-1273 biologics for COVID-19 developed by Pfizer/BioNTech and Moderna/National Institute of Allergy and Infectious […]
Millions of Americans Decline Second Dose of Experimental mRNA COVID-19 Vaccines
By the end of April 2021, more than five million people in the United States, or about eight percent of the population, had not received the second dose of the experimental mRNA Pfizer/BioNTech or Moderna/NIAID COVID-19 vaccines being distributed under an Emergency Use Authorization (EUA) granted by the U.S. Food and Drug Administration (FDA).